$39.78
+1.45 (+3.78%)
Open$37.98
Previous Close$38.33
Day High$41.72
Day Low$35.00
52W High$910.00
52W Low$15.10
Volume—
Avg Volume76.4K
Market Cap32.27M
P/E Ratio—
EPS$-125.71
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 548.9K | 523.5K | 509.5K |
| Net Income | 128.1K | 108.5K | 123.6K |
| Profit Margin | 23.3% | 20.7% | 24.3% |
| EBITDA | 177.1K | 173.7K | 174.5K |
| Free Cash Flow | 145.7K | 139.2K | 108.0K |
| Rev Growth | +23.9% | +19.4% | -4.0% |
| Debt/Equity | 0.65 | 0.64 | 0.76 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |